TY - JOUR
T1 - The global alliance for pediatric pharmacology
T2 - The future is here and now
AU - Koren, Gideon
AU - Rieder, Michael
AU - MacLeod, Stuart M.
PY - 2009
Y1 - 2009
N2 - The vast majority of drugs prescribed for children have not been approved by regulatory agencies for the pediatric age group and, in many cases, have not been studied appropriately. In July 2008, at a meeting of pediatric pharmacologists from over 30 countries and 5 continents in Toronto, ON, Canada, it became apparent that numerous pediatric drug studies are being conducted, often duplicating studies done elsewhere. This is also true for pharmacokinetic and pharmacodynamic studies, as well as for the development of pediatric formulations. Finding simple ways to inform the world about existing data may save time and facilitate efforts.
AB - The vast majority of drugs prescribed for children have not been approved by regulatory agencies for the pediatric age group and, in many cases, have not been studied appropriately. In July 2008, at a meeting of pediatric pharmacologists from over 30 countries and 5 continents in Toronto, ON, Canada, it became apparent that numerous pediatric drug studies are being conducted, often duplicating studies done elsewhere. This is also true for pharmacokinetic and pharmacodynamic studies, as well as for the development of pediatric formulations. Finding simple ways to inform the world about existing data may save time and facilitate efforts.
KW - Children
KW - Legislation
KW - Pharmacology
KW - Prescribing
KW - Research and development
UR - https://www.scopus.com/pages/publications/58149339919
U2 - 10.2165/0148581-200911010-00002
DO - 10.2165/0148581-200911010-00002
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 19127940
AN - SCOPUS:58149339919
SN - 1174-5878
VL - 11
SP - 4
EP - 5
JO - Pediatric Drugs
JF - Pediatric Drugs
IS - 1
ER -